Impact of functionality and grading on survival in pancreatic neuroendocrine tumor patients receiving peptide receptor radionuclide therapy
BackgroundPeptide receptor radionuclide therapy (PRRT) is a well-established treatment option for neuroendocrine tumors (NET), yet randomized controlled trials have not provided data on its impact on overall survival. The real-world efficacy of PRRT and its association with tumor functionality and g...
Enregistré dans:
| Auteurs principaux: | , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Frontiers Media S.A.
2025-04-01
|
| Collection: | Frontiers in Endocrinology |
| Sujets: | |
| Accès en ligne: | https://www.frontiersin.org/articles/10.3389/fendo.2025.1526470/full |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|
